Publication | Closed Access

Design of azidoproline containing gluten peptides to suppress CD4+ T-cell responses associated with Celiac disease

InflammationAllergyAutoimmune DiseaseCeliac DiseaseMedicineGluten PeptidesImmunologyPeptide TherapeuticAntigen ProcessingAutoimmunityPeptide TherapeuticsImmunotherapyCd4+ T-cell Responses